Everolimus

Accurate everolimus measurement supports therapeutic drug monitoring in transplant patients to guide dosing adjustments and minimize toxicity, and UTAK’s quality control catalog includes materials containing everolimus within human whole blood matrices to help laboratories validate assay performance and ensure accurate, reproducible results. Stock products such as Immunosuppressants Level 1-3 combine everolimus with related analytes including cyclosporine, sirolimus, and tacrolimus across defined concentration levels to support a range of clinical testing platforms. Custom immunosuppressant quality control solutions featuring everolimus and other analytes can be tailored to meet your laboratory’s specific therapeutic drug monitoring needs.